Követés
Mark Kriegsmann
Mark Kriegsmann
Institut of Pathology, Heidelberg University
E-mail megerősítve itt: med.uni-heidelberg.de
Cím
Hivatkozott rá
Hivatkozott rá
Év
Sarcoma classification by DNA methylation profiling
C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ...
Nature communications 12 (1), 498, 2021
2822021
MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics
J Kriegsmann, M Kriegsmann, R Casadonte
International journal of oncology 46 (3), 893-906, 2015
1792015
Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation
A Gewies, O Gorka, H Bergmann, K Pechloff, F Petermann, KM Jeltsch, ...
Cell reports 9 (4), 1292-1305, 2014
1572014
Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer
M Reichert, B Bakir, L Moreira, JR Pitarresi, K Feldmann, L Simon, ...
Developmental cell 45 (6), 696-711. e8, 2018
1252018
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
Y Lan, M Moustafa, M Knoll, C Xu, J Furkel, A Lazorchak, TL Yeung, ...
Cancer cell 39 (10), 1388-1403. e10, 2021
1052021
Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues
R Casadonte, M Kriegsmann, F Zweynert, K Friedrich, G Bretton, M Otto, ...
Proteomics 14 (7-8), 956-964, 2014
902014
MALDI mass spectrometry imaging: A cutting‐edge tool for fundamental and clinical histopathology
R Longuespée, R Casadonte, M Kriegsmann, C Pottier, ...
PROTEOMICS–Clinical Applications 10 (7), 701-719, 2016
882016
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
H Jiang, RJ Torphy, K Steiger, H Hongo, AJ Ritchie, M Kriegsmann, ...
The Journal of clinical investigation 130 (9), 4704-4709, 2020
862020
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity …
M Kriegsmann, V Endris, T Wolf, N Pfarr, A Stenzinger, S Loibl, C Denkert, ...
Oncotarget 5 (20), 9952, 2014
862014
Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma: separating biology from technical artifacts
D Kazdal, V Endris, M Allgäuer, M Kriegsmann, J Leichsenring, ...
Journal of Thoracic Oncology 14 (11), 1935-1947, 2019
852019
Site‐to‐site reproducibility and spatial resolution in MALDI–MSI of peptides from formalin‐fixed paraffin‐embedded samples
A Ly, R Longuespée, R Casadonte, P Wandernoth, K Schwamborn, ...
PROTEOMICS–Clinical Applications 13 (1), 1800029, 2019
842019
Deep learning for the classification of small-cell and non-small-cell lung cancer
M Kriegsmann, C Haag, CA Weis, G Steinbuss, A Warth, C Zgorzelski, ...
Cancers 12 (6), 1604, 2020
832020
Reliable entity subtyping in non-small cell lung cancer by matrix-assisted laser desorption/ionization imaging mass spectrometry on formalin-fixed paraffin-embedded tissue …
M Kriegsmann, R Casadonte, J Kriegsmann, H Dienemann, ...
Molecular & Cellular Proteomics 15 (10), 3081-3089, 2016
832016
A laser microdissection-based workflow for FFPE tissue microproteomics: Important considerations for small sample processing
R Longuespée, D Alberts, C Pottier, N Smargiasso, G Mazzucchelli, ...
Methods 104, 154-162, 2016
802016
Increases in tumor N‐glycan polylactosamines associated with advanced HER2‐positive and triple‐negative breast cancer tissues
DA Scott, R Casadonte, B Cardinali, L Spruill, AS Mehta, F Carli, ...
PROTEOMICS–Clinical Applications 13 (1), 1800014, 2019
712019
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast—implications for tumor biology and pathological diagnosis
N Pfarr, M Kriegsmann, P Sinn, F Klauschen, V Endris, E Herpel, ...
Genes, Chromosomes and Cancer 54 (7), 444-452, 2015
702015
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells
M Rosenbaum, A Gewies, K Pechloff, C Heuser, T Engleitner, T Gehring, ...
Nature communications 10 (1), 2352, 2019
692019
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
CJ Nattenmüller, M Kriegsmann, D Sookthai, RT Fortner, A Steffen, ...
BMC cancer 18, 1-8, 2018
672018
MALDI imaging mass spectrometry—from bench to bedside
K Schwamborn, M Kriegsmann, W Weichert
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865 (7), 776-783, 2017
672017
Molecular driver alterations and their clinical relevance in cancer of unknown primary site
H Löffler, N Pfarr, M Kriegsmann, V Endris, T Hielscher, P Lohneis, ...
Oncotarget 7 (28), 44322, 2016
652016
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20